Accustem Sciences (ACUT) Payables (2021 - 2026)
Accustem Sciences (ACUT) posted quarterly Payables of $737549.0 for Q1 2026, down 13.13% year-over-year from $849071.0 in Q1 2025, and up 1.54% quarter-over-quarter from $726358.0 in Q4 2025.
Accustem Sciences (ACUT) Payables (2021 - 2026) Analysis & Trends
Accustem Sciences (ACUT) has reported Payables for 6 consecutive years, with $737549.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 13.13% year-over-year to $737549.0; the TTM figure through Mar 2026 stood at $737549.0 (down 13.13% YoY), while the FY2025 annual figure was $726358.0, down 12.46% from the prior year.
- Payables advanced to $737549.0 in Q1 2026 per ACUT's latest filing, from $726358.0 in the prior quarter.
- Across five years, Payables topped out at $967880.0 in Q3 2025 and bottomed at $307075.0 in Q1 2023.
- Historically, Payables has averaged $653934.9 across 5 years, with a median of $680649.0 in 2023.
- Annual changes were most pronounced in 2023 — Payables slipped 18.97% — and 2024, when it soared 111.51%.
- Accustem Sciences' Payables stood at $418385.0 in 2022, then jumped by 51.55% to $634057.0 in 2023, then jumped by 30.87% to $829763.0 in 2024, then fell by 12.46% to $726358.0 in 2025, then grew by 1.54% to $737549.0 in 2026.
- Business Quant data shows ACUT's Payables at $737549.0 in Q1 2026, $726358.0 in Q4 2025, and $967880.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 35.57 Mn |
| 10 | Accustem Sciences | 2.57 Mn | 2.56 Mn | - | 678,233.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 737,549.00 |
| Dec 31, 2025 | 726,358.00 |
| Sep 30, 2025 | 967,880.00 |
| Jun 30, 2025 | 926,360.00 |
| Mar 31, 2025 | 849,071.00 |
| Dec 31, 2024 | 829,763.00 |
| Sep 30, 2024 | 847,838.00 |
| Jun 30, 2024 | 825,910.00 |
| Mar 31, 2024 | 649,480.00 |
| Dec 31, 2023 | 634,057.00 |
| Sep 30, 2023 | 545,115.00 |
| Jun 30, 2023 | 680,649.00 |
| Mar 31, 2023 | 307,075.00 |
| Dec 31, 2022 | 418,385.00 |
| Sep 30, 2022 | 366,945.00 |
| Jun 30, 2022 | 425,488.00 |
| Mar 31, 2022 | 378,970.00 |
| Dec 31, 2021 | 388,681.00 |